Welcome to Westonci.ca, where your questions are met with accurate answers from a community of experts and enthusiasts. Get detailed answers to your questions from a community of experts dedicated to providing accurate information. Discover detailed answers to your questions from a wide network of experts on our comprehensive Q&A platform.

cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model

Sagot :

Clinical practitioners in the United States continue to underutilize inhaled corticosteroids in the management of mild-to-moderate adult asthma.

In a cohort of patients aged 18 and older with FEV(1) values between 60% and 100% of predicted normal, the aim of this experiment was to determine the clinical effects, health-related quality of life, cost, and cost-effectiveness of inhaled corticosteroid therapy.

We compared the use of inhaled corticosteroid therapy along with quick relievers (such as short-acting beta-agonists) on an as-needed basis to the use of quick relievers alone.

To predict symptoms, acute exacerbations, quality-adjusted life years (QALYs), health care expenses, and cost-effectiveness, evaluated in both dollars per QALY gained and dollars per symptom-free day gained, a mathematical simulation model was created.

Learn more about corticosteroids:

https://brainly.com/question/28255810

#SPJ4

The complete question is '' what is the cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model''.